跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 477 条关于
“NMDAR 2C/2D”
全部
477
临床试验
325
药物
42
机构
1
资讯
109
3个月前
ReST Therapeutics Receives FDA Clearance for First-in-Human Trial of Novel Early PTSD Intervention RST-101
2个月前
Dynamic Single-Cell Transcriptomic Analysis Reveals Immune Dysregulation in Anti-NMDAR Encephalitis
3个月前
SLC6A20-Targeting ASO Restores NMDA Receptor Function in Autism Models, Offering New Therapeutic Strategy
去年
Atamyo Therapeutics' ATA-200 Gene Therapy Receives FDA Clearance for US Clinical Trial in LGMD2C/R5
去年
Pearl Achieves Historic FDA Clearance for First AI Platform Supporting Both 2D and 3D Dental Imaging Analysis
去年
First Patient Dosed in Phase 1 Trial of ABS-0871 for Charcot-Marie-Tooth Disease 2C Treatment
16天前
Multicellular 3D Tumor Spheroids Emerge as a Predictive Bridge Between 2D Assays and Solid Tumors in Preclinical Drug Testing
去年
iTeos Therapeutics Announces Strategic Priorities for 2025, Anticipating Multiple Data Readouts
去年
iTeos Therapeutics Announces Pipeline Updates and Financial Results for Q3 2024
去年
Silo Pharma's SPC-15 Demonstrates Promising Preclinical Results for Stress-Related Disorders
第 1 页,共 11 页
上一页
下一页